Genedata Harvard Case Solution & Analysis

IMD-1-0240 © 2005
Leleux, Benoit, F; Pahwa, Atul

Enterprise Valuation runs an independent valuation of Genedata; a Swiss start-up company to be able to help Novartis Venture Fund examine and structure the next funding round. Enterprise Valuation; under a tight investment timeframe; has to customize the evaluation process; using both quantitative and qualitative data; to fulfill the customers needs.

The case summarizes competitive positioning; its product portfolio; Genedata’s history; and dilemmas that it'll need to cope with in the not too distant future. Learning Objective: This case a part of a three case series meant to draw the audience into the problems surrounding the valuation of a startup biotechnology company; one of the most insecure and volatile market.

Subjects: Biotechnology; Valuation; Start-up; Entrepreneurship; Pharmaceuticals; Genomics; Software; Development Stage enterprise
Settings: Basel; Switzerland; Biotechnology; Pharmaceutical; Start up; 2000-2005

Genedata Case Solution Other Similar Case Solutions like


Share This